Glaxosmithkline Share News (GSK)

TOP NEWS: UK Construction Output Falls Unexpectedly In January

London open: Stock markets flat ahead of quiet day

UK stocks were more or less flat in early deals on Friday ahead of a quiet day for the markets in terms of economic data and corporate news. London's FTSE 100 was trading up just 0.01% at 6,761.79 early on. As it stands, the Footsie is still nearly 3% lower than where it stood last Friday as a stre

UK MORNING BRIEFING: JD Wetherspoon And Afren Down On Pre-Market News

London pre-open: Stocks to edge higher early on

UK stocks are expected to edge higher on Friday morning as markets continue to attempt to claw back heavy losses made earlier in the week. City sources predict the FTSE 100 will open around 10 points higher than Thursday's close of 6,761.07. As it stands, the Footsie is still nearly 3% lower than w

UPDATE 2-GSK raises $853 mln by halving stake in S.African drugmaker

* Sells 28.2 million Aspen shares for 372 rand each * GSK says move increases "financial flexibility" * British group retains 6.2 percent stake in Aspen (Updates with actual amount raised following sale) LONDON, March 13 (Reuters) - GlaxoSmithKline has taken profits in Aspen P

Glaxo completes part sale of Aspen stake

Glaxosmithkline has sold half its stake in former South African associate Aspen Pharmacare for £0.574bn. Having sold 28.2m shares, at a price of 372 rand per share, GSK now holds a 6.2% stake in Aspen, South Africa's largest drug company. Glaxo has agreed not to dispose of any further shares in Asp

PRESS: J&J Sues Glaxo Over False Advertising Claims - Reuters

Johnson & Johnson sues Glaxo over allergy ads as spring nears

By David Ingram NEW YORK, March 12 (Reuters) - Johnson & Johnson sued rival drugmaker GlaxoSmithKline PLC on Thursday, alleging that Glaxo is trying to unlawfully grab market share with false advertising at the start of spring allergy season in the United States. Two Johnson & Johnso

London close: Gains pared but markets buoyed by pharma, beverage stocks

UK stocks were off their highest levels of the day by the close on Thursday as mining shares erased earlier gains, though strong performances from pharma and beverage groups provided some support, as well as M&A in the banking sector. The FTSE 100 finished the session up 39.56 points (+0.6%) at 6,76

UPDATE 1-GSK to pocket $890 mln by halving stake in S.African drugmaker

(Adds GSK executive's comments, details) LONDON, March 12 (Reuters) - GlaxoSmithKline has decided to take profits in Aspen Pharmacare by halving its stake in the South African drugmaker, following a long investment in the firm. The sale will be conducted through a share placing at a d

GSK to sell half of Aspen Pharma stake

GlaxoSmithKline (GSK) has revealed it plans to sell half of its 12.4% stake in South Africa's largest drug company, Aspen Pharmacare. Aspen shares currently trade at 40,650 South African rand, valuing it at roughly 185.3bn rand (£10.15bn). "GSK has a long and successful commercial partnership with

GSK launches $890mln placement in Aspen Pharmacare - source

LONDON, March 12 (Reuters) - GlaxoSmithKline has launched a $890 million share sale in South African drug company Aspen Pharmacare, a source familiar with the matter said on Thursday. GSK said earlier on Thursday that it had launched the sale of around half its holding in the company. A pri

GlaxoSmithKline To Sell Half Of Its Stake In Aspen Pharmacare

FTSE 100 movers: Astrazeneca soars on new diabetes research, RBS higher on upgrade

AstraZeneca topped the risers as it committed $40m to backing phase 2a trials for a new diabetes drug - a form of long-acting insulin that only needs to be administered once week. Glaxosmithkline was boosted by news it plans to sell approximately half of its 12.4% stake in Aspen Pharmacare Holdings.

UPDATE 1-Drugmaker GSK to steer Asian business from new Singapore HQ

* 100 job roles to move to Singapore * New HQ slated for completion in late 2016 (Adds details, CEO comments) SINGAPORE/LONDON, March 11 (Reuters) - Drugmaker GlaxoSmithKline will establish a new headquarters for Asia in Singapore to make quicker decisions for the region, a move tha